The P&R Group, the owner of Italian API manufacturer Olon, has agreed to acquire its compatrior Infa. The transaction, which should be completed in early July at the latest, will create a player with sales of over €300 million/year and “a significant player in Europe as well as in the US”, it claimed. Based at Rodano, near Milan, P&R owns SIR and Fidia Farmaceutici as well as Olon.
The board of the Indian pharmaceutical company Strides Shasun has notified the National Stock Exchange of India of its intention to divest Shasun Pharma Solutions to its current management for an enterprise value of €31.8 million, with funding from the promoter group of Strides Shasun. The transaction is expected to be completed in Q3, the second quarter of its own fiscal year.
Evonik Industries is acquiring the Performance Materials division of Air Products & Chemicals in a $3.8 billion deal which had been the subject of market rumours for several months. Air Products still intends to spin off the rest of its Materials Technologies segment, the Electronic Materials division, to shareholders as a separate public company called Versum Materials.
AMRI has signed a definitive agreement to acquire the Italian API manufacturer Euticals in a cash, share and seller note transaction valued at about $385 million. The deal, said company president and CEO William Marth, “will provide us an established custom synthesis presence in Europe and will further build on our expertise in complex APIs”. It will also make AMRI one of the global giants in fine chemicals.
Deal should go through to commercial manufacture
Published: April 18, 2016
Western suppliers of pharmaceutical fine chemical suppliers are doing well right now, but will it last? We report from DCAT Week ‘16